Investor Stock List
Ranked #3,740 of 8,699 institutional investors

Catalio Capital Management, LP

New York, NY

$472M
US stock portfolio at live prices · today −$5.4M (−1.14%)
Live prices, last trade 11:32 AM ET
Value at quarter end (Q3 2026)
$538M
Change from Q2 2026
+$6.2M (+1.17%)
Positions
44 · 13 new, 5 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$39.3M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
AVLN 10.1%BBIO 6.96%BMY 6.30%JNJ 5.72%PBLS 4.86%
StockSharesValue, live% of portfoliovs Q2 2026
AVLN Avalyn Pharma Inc.1,698,851$47.9M10.1%Added +1%
BBIO BridgeBio Pharma, Inc.425,111$32.8M6.96%Reduced −7%
BMY Bristol-Myers Squibb Company499,716$29.7M6.30%Added +21%
JNJ Johnson & Johnson99,496$27.0M5.72%Reduced −28%
PBLS Parabilis Medicines, Inc.824,043$22.9M4.86%Unchanged
SEPN Septerna, Inc.454,015$17.8M3.76%Reduced −15%
EW Edwards Lifesciences Corporation161,121$16.6M3.52%Added +29%
DFTX Definium Therapeutics, Inc.497,964$14.5M3.07%Reduced −12%
PTGX Protagonist Therapeutics, Inc.112,418$13.8M2.92%Added +5%
ARWR Arrowhead Pharmaceuticals, Inc.315,247$13.5M2.86%New
GH Guardant Health, Inc.92,579$13.5M2.86%New
AMLX Amylyx Pharmaceuticals, Inc.505,882$13.1M2.77%New
IRON Disc Medicine, Inc.172,709$12.9M2.74%Added +8%
CELC Celcuity Inc.230,609$12.6M2.67%New
MANE Veradermics Inc95,646$11.6M2.46%Added +109%
RARE Ultragenyx Pharmaceutical Inc.601,760$10.0M2.13%Added +90%
CRVS Corvus Pharmaceuticals, Inc.1,021,499$9.9M2.10%Reduced −5%
RYTM Rhythm Pharmaceuticals, Inc.85,614$9.7M2.06%New
SNDX Syndax Pharmaceuticals, Inc.1,023,510$9.1M1.94%Reduced −16%
BMRN BioMarin Pharmaceutical Inc.144,971$8.9M1.88%New
TXG 10x Genomics, Inc.164,029$8.7M1.83%New
MLYS Mineralys Therapeutics, Inc.583,364$8.2M1.73%Reduced −10%
ODTX Odyssey Therapeutics, Inc.457,839$8.0M1.69%Unchanged
FDMT 4D Molecular Therapeutics, Inc.684,753$7.3M1.54%Added +45%
ANNX Annexon, Inc.1,986,806$6.4M1.36%New
IMCR Immunocore Holdings plc211,985$5.6M1.20%Added +43%
KLRA Kailera Therapeutics, Inc.468,750$5.4M1.14%Unchanged
COGT Cogent Biosciences, Inc.167,716$4.5M0.96%New
GPCR Structure Therapeutics Inc.260,109$4.3M0.91%Reduced −6%
NKTR Nektar Therapeutics126,817$4.0M0.84%New
KARD Kardigan, Inc.312,500$3.8M0.81%Unchanged
NTRA Natera, Inc.12,530$3.5M0.74%Reduced −85%
HTFL Heartflow, Inc.74,969$3.4M0.73%Reduced −87%
KRSA Korsana Biosciences, Inc.87,702$3.3M0.70%New
ELDN Eledon Pharmaceuticals, Inc.1,637,114$2.9M0.62%Reduced −3%
FRNM Freenome, Inc.158,170$1.5M0.32%New
BBOT BridgeBio Oncology Therapeutics, Inc.699,532$1.3M0.27%Added +120%
TARA Protara Therapeutics, Inc.512,287$1.2M0.25%Reduced −2%
HYPR Hyperfine, Inc.1,303,155$645K0.14%Reduced −1%
OM Outset Medical, Inc.107,456$313K<0.1%Reduced −9%
MGX Metagenomi Therapeutics, Inc.528,993$305K<0.1%Unchanged
ADRX ADARx Pharmaceuticals, Inc.11,357$160K<0.1%New
FTH Faeth Therapeutics, Inc.14,718$127K<0.1%Unchanged
KPTIQ Karyopharm Therapeutics Inc.976,191$33K<0.1%Added +4%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
GILD Gilead Sciences, Inc.269,309$45.5M
INCY Incyte Corporation191,627$22.1M
AXSM Axsome Therapeutics, Inc.43,182$5.6M
DYN Dyne Therapeutics, Inc.244,929$3.9M
DNTH Dianthus Therapeutics, Inc.32,941$2.8M